Stroke In 2017, Concord Hospital improved performance in delivering timely treatment to eligible patients experiencing stroke caused by a clot obstructing a blood vessel supplying blood to the brain (acute ischemic stroke).  Reducing the time between stroke patients’arrival in the Emergency Department (ED) to when they are treated with a clot-busting medication (door-to-needle time) can help reduce disability.To help improve our stroke patients’outcomes, we redesigned the ED stroke activation process to provide timelier assessments, diagnostics and treatment. National stroke guidelines recommend a door-to-needle time of 60 minutes or less for patients experiencing acute ischemic stroke. From January 1 to September 8, 2017, Concord Hospital administered clot-busting medication to 78 percent of eligible patients in less than 60 minutes.The American Heart Association reports studies have found that only 53.3 percent of U.S. patients are treated within this crucial window.With stroke treatment,‘time is brain’as human nervous system tissue is lost rapidly as a stroke progresses. We striveforexcellenceinallwedo. ChristinaSwanberry,RN CONCORD HOSPITAL STROKE PROGRAM MANAGER ConcordHospital’sStrokeProgram isacollaborationthatincludeseveryone fromfamilymemberswhorecognizestroke symptomsbecauseofHospitaloutreach programstofirstresponders,Hospital personnel,rehabilitationspecialists,primary carephysiciansandadvancedproviders. 10 Leading with Quality, Safety and Service